GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Imugene Ltd (OTCPK:IUGNF) » Definitions » 5-Year Yield-on-Cost %

IUGNF (Imugene) 5-Year Yield-on-Cost % : 0.00 (As of Dec. 15, 2024)


View and export this data going back to . Start your Free Trial

What is Imugene 5-Year Yield-on-Cost %?

Imugene's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Imugene's 5-Year Yield-on-Cost % or its related term are showing as below:



IUGNF's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.57
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Imugene's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Imugene's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Imugene's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Imugene's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Imugene's 5-Year Yield-on-Cost % falls into.



Imugene 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Imugene is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Imugene  (OTCPK:IUGNF) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Imugene 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Imugene's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Imugene Business Description

Traded in Other Exchanges
Address
4-6 Bligh Street, Suite 12.01, Level 12, Sydney, NSW, AUS, 2000
Imugene Ltd specializes in a clinical-stage immuno-oncology company. Its products include HER-Vaxx, PD1-Vaxx, CF33 and CF33 CD19. HER-Vaxx is a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment is the Research and Development of oncolytic immunotherapies.